Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07315516

The Effects of Natural Bioactive Compounds on Sleep and Stress: A Randomized Double-Blind Placebo-Controlled Trial

Led by RDC Clinical Pty Ltd · Updated on 2026-04-23

240

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

R

RDC Clinical Pty Ltd

Lead Sponsor

G

Gencor Pacific Limited, Hong Kong

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of natural supplements—lavender oil, palmitoylethanolamide (PEA), and oleoylethanolamide (OEA)—on improving sleep quality and reducing stress and anxiety in adults with moderate stress levels and sleep difficulties. This phase 2 randomized, double-blind, placebo-controlled trial aims to understand how these supplements work and their safety when taken daily. The study involves 240 adults with a Perceived Stress Scale (PSS) score of 14 or higher and sleep complaints occurring at least twice a week. Participants are randomly assigned to one of four groups: lavender oil, PEA, OEA, or a placebo group. Each participant takes one capsule daily for 8 weeks (57 days). The active supplements and placebo capsules look identical to maintain blinding. The study uses validated questionnaires and collects saliva samples to assess stress, sleep patterns, and hormone levels throughout the intervention. During the study, participants attend two clinic visits and have a phone check-in between visits. Researchers monitor stress, anxiety, sleep quality, mood, and mental wellbeing using questionnaires from day 1 to day 57. They also measure sleep duration, sleep onset latency, sleep efficiency, daytime sleepiness, and stress-related eating. Safety is assessed by tracking adverse events and vital signs like blood pressure, heart rate, oxygen saturation, and temperature. The total participation lasts for the 8-week intervention period.

CONDITIONS

Brief Title

Sleep and Stress Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Generally healthy adults aged 18 and over
  • Able to provide informed consent
  • Score of at least 14 on the Perceived Stress Scale (PSS)
  • Sleep complaints occurring at least twice per week, including difficulty initiating or maintaining sleep, or early awakening causing distress or impairment
  • Agree to avoid other dietary supplements for sleep, depression, stress, or anxiety during the study
  • Agree to maintain current diet and exercise routines during the study
  • Agree not to participate in another clinical trial during the study period
Not Eligible

You will not qualify if you...

  • WHO-5 Well-Being Index score of 28 or less
  • Severe sleep complaints with an Insomnia Severity Index above 21
  • Taking prescribed medication for sleep, depression, or anxiety
  • Having serious illnesses such as asthma, depression, anxiety disorder, bipolar disorder, insomnia, organic sleep disorders, neurological disorders, kidney, liver, or heart conditions
  • Having unstable illnesses like diabetes or thyroid dysfunction
  • Current malignancy or cancer treatment within the past 2 years (excluding basal cell carcinoma)
  • Taking anticoagulation therapy including Coumadin, Heparin, Dalteparin, Enoxaparin, or low-dose aspirin
  • Active smokers or drug abuse
  • Chronic alcohol use exceeding 21 drinks per week
  • Consuming more than 500mg caffeine daily
  • Pregnant or lactating women
  • Allergic to any ingredients in the active or placebo capsules
  • Currently or recently participating in another clinical trial within the past month
  • Any condition deemed unsuitable by the investigator for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 57 days

Participants take one capsule daily of either lavender oil, palmitoylethanolamide (PEA), oleoylethanolamide (OEA), or a placebo for 57 days while their stress, anxiety, sleep quality, and related biomarkers are assessed.

Weekly visits for up to 8 weeks

Trial Site Locations

Total: 1 location

1

RDC Clinical

Brisbane, Australia

Actively Recruiting

Loading map...

Research Team

A

Amanda Rao, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Similar Trials

Erectile Function After Percutaneous Coronary Intervention i...

Erectile Disfunction

Actively Recruiting

1 location

A Feasibility Trial of Eye Movement Desensitization and Repr...

Post Traumatic Stress Symptoms

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here